A Danish study published online January 22 in the Oncologist shows that PET/CT and biomarkers can help clinicians predict treatment response in patients with metastatic colon cancer.  Dr. Bodil Engelmann, from Næstved Hospital, and colleagues conducted a prospective study to determine the predictive value of several established biomarkers and FDG-PET/CT in the early response of metastatic colon cancer to treatment with chemotherapy. {read more here}